The Genomics and Precision Medicine Expo – taking place on 23 and 24 May 2023 at ExCeL London – has announced the top 5 highlights for this year’s inaugural conference.
The event, run in partnership with Genomics England, will explore the latest advances and developments in genome sequencing and genomic testing, as well as the immediate and future potential for the development of precision medicine within the NHS and beyond.
The two days of content will cover topics ranging from discovery, research, development, and regulatory assessment, to patient delivery, supply, and referral.
Lucy Clarke, event manager for the Genomics and Precision Medicine Expo, said: “This event is a unique opportunity to discover important updates, gain practical learning that you can apply to your own work, and share insights with like-minded colleagues in patient care and science. With the UK being a major world leader in genomics and life sciences testing, there is a wealth of knowledge to be shared at the Genomics and Precision Medicine Expo.”
First day highlight
The first day includes sessions on precision cancer medicine: advances, limitations and opportunities. Precision medicine is the desire to tailor each person’s treatment according to the underlying biology of their disease.
Also on the first day, lectures in the afternoon will address the application of whole genome sequencing to routine clinical practice. All children in the UK with cancer are eligible for somatic and germline whole genome sequencing (WGS) through the NHS Genomic Medicine Service. Jack Bartram, consultant pediatric hematologist at Great Ormond Street Hospital for Children (GOSH), will describe his experience using WGS for hematological malignancies to elicit, analyze, and integrate clinical results in meaningful timeframes.
Another highlight was the panel discussion on navigating patient consent in cancer genomics. The use of genomic testing in routine care brings benefits to patient care and treatment, but it can also present new challenges for clinicians around consent. In this panel session involving representatives from Genomics England and The Royal Marsden NHS Foundation Trust, guests will explore different scenarios and approaches for approving cancer patients for genomic testing.
Highlight of the second day
On the second day, an afternoon presentation will look at the role of the nurse in transforming genomic healthcare. The application of genomics in everyday practice is now a reality in the treatment of cancer and rare diseases. Tootie Bueser, director of nursing & midwifery and chief nurse – Southeast Genomic Medicine Service Alliance and North Thames Genomic Medicine Service Alliance will explore how nurses have a critical role to play in transforming care through genomics and need access to education, training and other resources to make the most of it. this is an opportunity.
The final highlight was a session on pharmacogenomics, hosted by Nisha Shaunak, chief associate pharmacist – Cancer, TRU and Surgery Clinical Group, Guy’s & St Thomas’ NHS Foundation Trust.
Co-located with the Oncology, Genomics and Precision Medicine Professional Care Expo, the event is free to attend for registered healthcare professionals and individuals working in genomics and precision medicine (excluding commercial companies) and is fully accredited by the CPD.
The co-located event features 150+ sessions across seven focused theaters with product and service providers showcasing the latest innovations on the show floor.
About Genomics and Precision Medicine Exhibition
The Genomics and Precision Medicine Expo intends to interest leaders in Public Health and ICS, CCIOs within the NHS and private sector, clinicians working in acute and primary care who wish to expand their knowledge and understanding of the fast-paced developments in the sector, and clinical scientists. and biomedical.
Free attendance for UK healthcare professionals and individuals working in genomics and precision medicine (in non-commercial roles). Register here: genomicsprecisionmedicine.co.uk